Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Browse Lab Results > 2009-0562

Trial Summary

About CDAS Project, PI, Publications: Serum Estrogens and Subsequent Risk of Prostate Cancer

Datasets

Site: Prostate

Inclusion Criteria:

  • All I-Arm Men
  • No Prior History of Prostate Cancer
  • White, Non-Hispanic
  • Not From Hawaii Center
  • No Rare Cancers in Controls
  • Perfect Serum at T0 or .5+ ml child or in 2008-256,2009-555, or 2009-565
  • Incident (Cases Only)
  • In Prostate BPC3 Biochemical
  • In Final Population (Original Selection Line)
  • Has .5ml of Serum Available
  • Updated Advanced Case or Updated Control
  • Updated Case with Age at Dx <= 70 or Updated Control
  • Exclude All Rare Cancers
  • No Controls With no Results
  • Matched Cases at a 1-1 Ratio

Matching Factors:

  • Age at Randomization (5 year intervals)
  • Original Draw Year

Match Ratio: 1 to 1

Match Technique: Frequency matching only non-cases as controls.

Analytes:

  • 16-Epiestriol
  • 16-Ketoestradiol
  • 16Alpha-Hydroxyestrone
  • 17-Epiestriol
  • 2-Hydroxyestradiol
  • 2-Hydroxyestrone
  • 2-Hydroxyestrone-3-Methyl Ether
  • 2-Methoxyestradiol
  • 2-Methoxyestrone
  • 4-Hydroxyestrone
  • 4-Methoxyestradiol
  • 4-Methoxyestrone
  • Estradiol
  • Estriol
  • Estrone

Number of Cases: 195

Number of Controls: 195